These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17905301)

  • 1. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.
    Shata MT; Barrett A; Shire NJ; Abdelwahab SF; Sobhy M; Daef E; El-Kamary SS; Hashem M; Engle RE; Purcell RH; Emerson SU; Strickland GT; Sherman KE
    J Immunol Methods; 2007 Dec; 328(1-2):152-61. PubMed ID: 17905301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
    Brown A; Halliday JS; Swadling L; Madden RG; Bendall R; Hunter JG; Maggs J; Simmonds P; Smith DB; Vine L; McLaughlin C; Collier J; Bonsall D; Jeffery K; Dunachie S; Klenerman P; Izopet J; Kamar N; Dalton HR; Barnes E
    Hepatology; 2016 Dec; 64(6):1934-1950. PubMed ID: 27631819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.
    Eldin SS; Seddik I; Daef EA; Shata MT; Raafat M; Abdel Baky L; Nafeh MA
    Egypt J Immunol; 2010; 17(1):73-86. PubMed ID: 22053611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection.
    Pisanic N; Rahman A; Saha SK; Labrique AB; Nelson KE; Granger DA; Granger SW; Detrick B; Heaney CD
    J Immunol Methods; 2017 Sep; 448():1-8. PubMed ID: 28478117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector T cells immune reactivity among patients with acute hepatitis E.
    Husain MM; Aggarwal R; Kumar D; Jameel S; Naik S
    J Viral Hepat; 2011 Oct; 18(10):e603-8. PubMed ID: 21914082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of two immunoassays for serological diagnosis of hepatitis E.
    Sampedro A; Casanovas I; Ceballos J; Rodriguez-Granger J; Cobo F; Navarro JM
    J Med Virol; 2020 Feb; 92(2):260-262. PubMed ID: 31579928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.
    Tripathy AS; Das R; Rathod SB; Arankalle VA
    PLoS One; 2012; 7(2):e31822. PubMed ID: 22384080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.
    Goldsmith R; Yarbough PO; Reyes GR; Fry KE; Gabor KA; Kamel M; Zakaria S; Amer S; Gaffar Y
    Lancet; 1992 Feb; 339(8789):328-31. PubMed ID: 1346411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.
    Forrest BD; Pride MW; Dunning AJ; Capeding MR; Chotpitayasunondh T; Tam JS; Rappaport R; Eldridge JH; Gruber WC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1042-53. PubMed ID: 18448618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
    Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
    J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a fluorescent microbead-based immunoassay for the detection of hepatitis E virus IgG antibodies in pigs and comparison to an enzyme-linked immunoassay.
    Owolodun OA; Giménez-Lirola LG; Gerber PF; Sanford BJ; Feagins AR; Meng XJ; Halbur PG; Opriessnig T
    J Virol Methods; 2013 Nov; 193(2):278-83. PubMed ID: 23773809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
    Zhang Q; Zong X; Li D; Lin J; Li L
    Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.
    Kuebler PJ; Mehrotra ML; McConnell JJ; Holditch SJ; Shaw BI; Tarosso LF; Leadabrand KS; Milush JM; York VA; Raposo RA; Cheng RG; Eriksson EM; McMahan V; Glidden DV; Shiboski S; Grant RM; Nixon DF; Kallás EG
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8379-84. PubMed ID: 26100867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatitis E virus in patients sera in southern Spain.
    Pérez-Gracia MT; García-Valdivia MS; Galán F; Rodríguez-Iglesias MA
    Acta Virol; 2004; 48(3):197-200. PubMed ID: 15595216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.
    Arankalle VA; Lole KS; Deshmukh TM; Chobe LP; Gandhe SS
    J Viral Hepat; 2007 Jun; 14(6):435-45. PubMed ID: 17501765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus.
    Li TC; Zhang J; Shinzawa H; Ishibashi M; Sata M; Mast EE; Kim K; Miyamura T; Takeda N
    J Med Virol; 2000 Nov; 62(3):327-33. PubMed ID: 11055242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in capabilities of different enzyme immunoassays to detect anti-hepatitis E virus immunoglobulin G in pigs infected experimentally with hepatitis E virus genotype 3 or 4 and in pigs with unknown exposure.
    Zhang H; Mohn U; Prickett JR; Schalk S; Motz M; Halbur PG; Feagins AR; Meng XJ; Opriessnig T
    J Virol Methods; 2011 Aug; 175(2):156-62. PubMed ID: 21596064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay.
    Engle RE; Yu C; Emerson SU; Meng XJ; Purcell RH
    J Clin Microbiol; 2002 Dec; 40(12):4576-80. PubMed ID: 12454155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.